+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biopharmaceutical Bioseparation Systems Market - Global Forecast 2026-2030- Product Image
Biopharmaceutical Bioseparation Systems Market - Global Forecast 2026-2030- Product Image
New

Biopharmaceutical Bioseparation Systems Market - Global Forecast 2026-2030

  • PDF Icon

    Report

  • 193 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6010879
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The biopharmaceutical bioseparation systems market is evolving rapidly, shaped by complex biologic products, stringent regulations, and the drive for process scalability and efficiency. Senior decision-makers face strategic choices as these technologies underpin future-ready pharmaceutical manufacturing.

Market Snapshot: Biopharmaceutical Bioseparation Systems Market Size and Growth

The biopharmaceutical bioseparation systems market grew from USD 14.10 billion in 2024 to USD 15.42 billion in 2025, and is projected to expand at a compound annual growth rate of 9.54%, ultimately reaching USD 24.38 billion by 2030. Strong sector growth is propelled by advances in bioprocessing technologies, widespread adoption of single-use solutions, increasing manufacturing demands, and shifting regulatory environments. Market activity consistently reflects the need for advanced, robust solutions that facilitate efficient production and quality assurance for high-value biologics and new therapeutic modalities.

Scope & Segmentation of the Biopharmaceutical Bioseparation Systems Market

  • Product Types: Centrifugation systems, including decanter, disc stack, and tubular bowl models; chromatography platforms, such as affinity, ion exchange, hydrophobic interaction, mixed-mode, and size exclusion; membrane filtration solutions covering microfiltration, nanofiltration, and ultrafiltration.
  • Operation Modes: Batch processing and continuous processing, including multi-column chromatography and perfusion-based workflows to support diverse manufacturing requirements and accelerate process development.
  • Material Formats: Multi-use platforms designed for extended lifecycles, alongside single-use assemblies including gamma-irradiated and presterilized flow paths for quicker implementation and reduced cross-contamination risks.
  • Applications: Encompasses cell clarification; protein purification for monoclonal antibodies, enzymes, peptides, and recombinant proteins; vaccine production; virus purification; and advanced polishing or final purification stages.
  • End Users: Biopharmaceutical manufacturers, academic research organizations, bioservices, and contract development and manufacturing organizations (CDMOs) engage with bioseparation systems for improved production quality and compliance.
  • Regional Coverage: Americas, Europe, Middle East & Africa, and Asia-Pacific, each presenting distinct opportunities and infrastructure readiness for market penetration and technology adoption.
  • Technologies: Chromatography, membrane filtration, high-throughput centrifugation, digital process analytics, and hybrid purification strategies offer tailored operational and scalability solutions.

Key Takeaways for Decision-Makers

  • Placing bioseparation systems at the intersection of process innovation, compliance, and commercial scale-up is essential for staying competitive in advanced biologics manufacturing.
  • Adoption of continuous processing and single-use systems streamlines changeovers and mitigates contamination, though it introduces considerations for supply chain management and waste reduction strategies.
  • Hybrid and integrated purification methods are vital as product portfolios diversify, demanding adaptable platforms and configurable process workflows to ensure operational flexibility.
  • Digital controls and real-time analytics now enable greater process transparency and predictability, aligning procurement choices with long-term operational and financial objectives.
  • Regional disparities in supply readiness, regulatory harmonization, and manufacturing capacity influence both the pace of technology adoption and the scale of local service requirements.
  • Effective partnerships across suppliers, CDMOs, and bioservices providers support differentiated offerings, leveraging modular system platforms, validated single-use technologies, and integrated services to stand out in a competitive market.

Tariff Impact and Regulatory Implications

Ongoing tariffs and changing trade policies in 2025 have encouraged procurement leaders to diversify supplier bases, review sourcing strategies, and develop modular, adaptable facilities. These cost pressures are driving regionalization, which impacts inventory management and necessitates close monitoring of regulatory documentation during supplier transitions. Regulatory scrutiny has intensified, especially when modifying processes or supplier networks, which in turn requires robust comparability studies and thorough analytical validation. For decision-makers, building procurement resilience and flexible operational structures is more important than ever.

Research Methodology & Data Sources

Insights in this assessment derive from a comprehensive mixed-methods approach, incorporating structured interviews with specialists, direct facility observations, extensive technical literature reviews, and triangulation of multiple data sources. This includes regulatory guidelines, peer-reviewed studies, published equipment specifications, and sensitivity analyses, creating a validated and balanced market perspective.

Why This Report Matters for Senior Decision-Makers

  • Clarifies the segmentation and technology landscape, empowering leaders to select and implement bioseparation systems that best align with operational priorities and organizational risk appetite.
  • Provides actionable perspectives on the effects of shifting regional supply chains, tariffs, and regulatory trends, supporting robust procurement and continuity strategies.
  • Helps prioritize investments toward supply chain resilience, modular infrastructure, and digital transformation initiatives to ensure long-term operational reliability and regulatory compliance.

Conclusion

As biopharmaceutical manufacturing transitions to more advanced, regulated, and scalable operations, organizations that integrate technical innovation with resilient supply and compliance frameworks will secure a lasting competitive edge in bioseparation and purification.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2024
3.5. FPNV Positioning Matrix, 2024
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Biopharmaceutical Bioseparation Systems Market, by Product Type
8.1. Centrifugation Systems
8.1.1. Decanter Centrifuge Systems
8.1.2. Disc Stack Centrifuge Systems
8.1.3. Tubular Bowl Centrifuge Systems
8.2. Chromatography Systems
8.2.1. Affinity Chromatography
8.2.1.1. Immobilized Metal Affinity Chromatography
8.2.1.2. Lectin Affinity Chromatography
8.2.1.3. Protein A Affinity Chromatography
8.2.2. Hydrophobic Interaction Chromatography
8.2.3. Ion Exchange Chromatography
8.2.4. Mixed-Mode Chromatography
8.2.5. Size Exclusion Chromatography
8.3. Membrane Filtration Systems
8.3.1. Microfiltration Systems
8.3.2. Nanofiltration Systems
8.3.3. Ultrafiltration Systems
9. Biopharmaceutical Bioseparation Systems Market, by Operation Mode
9.1. Batch Processing
9.2. Continuous Processing
9.2.1. Multi-Column Chromatography
9.2.2. Perfusion Processing
10. Biopharmaceutical Bioseparation Systems Market, by Material Format
10.1. Multi-Use
10.2. Single-Use
10.2.1. Gamma-Irradiated Flow Paths
10.2.2. Presterilized Assemblies
11. Biopharmaceutical Bioseparation Systems Market, by Application
11.1. Cell Clarification
11.2. Polishing & Final Purification
11.3. Protein Purification
11.3.1. Enzyme Purification
11.3.2. Monoclonal Antibodies
11.3.3. Peptide Purification
11.3.4. Recombinant Protein Purification
11.4. Vaccine Production
11.5. Virus Purification
12. Biopharmaceutical Bioseparation Systems Market, by End User
12.1. Academic & Research Institutes
12.2. Biopharmaceutical Companies
12.3. Bioservices
12.4. Contract Manufacturing Organizations
13. Biopharmaceutical Bioseparation Systems Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Biopharmaceutical Bioseparation Systems Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Biopharmaceutical Bioseparation Systems Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Biopharmaceutical Bioseparation Systems Market
17. China Biopharmaceutical Bioseparation Systems Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2024
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2024
18.3. Product Portfolio Analysis, 2024
18.4. Benchmarking Analysis, 2024
18.5. Agilent Technologies, Inc.
18.6. Alfa Laval AB
18.7. Asahi Kasei Corporation
18.8. Bio-Rad Laboratories, Inc.
18.9. GEA Group Aktiengesellschaft
18.10. Merck KGaA
18.11. Sartorius AG
18.12. Shimadzu Corporation
18.13. Tecan Trading AG
18.14. Thermo Fisher Scientific Inc.
18.15. Tosoh Bioscience LLC
List of Figures
FIGURE 1. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 2. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 3. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 4. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MATERIAL FORMAT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 13. CHINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 2. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 3. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY DECANTER CENTRIFUGE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY DECANTER CENTRIFUGE SYSTEMS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY DECANTER CENTRIFUGE SYSTEMS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY DISC STACK CENTRIFUGE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY DISC STACK CENTRIFUGE SYSTEMS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY DISC STACK CENTRIFUGE SYSTEMS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TUBULAR BOWL CENTRIFUGE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TUBULAR BOWL CENTRIFUGE SYSTEMS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TUBULAR BOWL CENTRIFUGE SYSTEMS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, BY GROUP, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY, BY GROUP, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY LECTIN AFFINITY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY LECTIN AFFINITY CHROMATOGRAPHY, BY GROUP, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY LECTIN AFFINITY CHROMATOGRAPHY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN A AFFINITY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN A AFFINITY CHROMATOGRAPHY, BY GROUP, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN A AFFINITY CHROMATOGRAPHY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY HYDROPHOBIC INTERACTION CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY HYDROPHOBIC INTERACTION CHROMATOGRAPHY, BY GROUP, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY HYDROPHOBIC INTERACTION CHROMATOGRAPHY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY ION EXCHANGE CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY ION EXCHANGE CHROMATOGRAPHY, BY GROUP, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY ION EXCHANGE CHROMATOGRAPHY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MIXED-MODE CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MIXED-MODE CHROMATOGRAPHY, BY GROUP, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MIXED-MODE CHROMATOGRAPHY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SIZE EXCLUSION CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SIZE EXCLUSION CHROMATOGRAPHY, BY GROUP, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SIZE EXCLUSION CHROMATOGRAPHY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MICROFILTRATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MICROFILTRATION SYSTEMS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MICROFILTRATION SYSTEMS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY NANOFILTRATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY NANOFILTRATION SYSTEMS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY NANOFILTRATION SYSTEMS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY ULTRAFILTRATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY ULTRAFILTRATION SYSTEMS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY ULTRAFILTRATION SYSTEMS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY BATCH PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY BATCH PROCESSING, BY GROUP, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY BATCH PROCESSING, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, BY GROUP, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MULTI-COLUMN CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MULTI-COLUMN CHROMATOGRAPHY, BY GROUP, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MULTI-COLUMN CHROMATOGRAPHY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PERFUSION PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PERFUSION PROCESSING, BY GROUP, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PERFUSION PROCESSING, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MATERIAL FORMAT, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MULTI-USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MULTI-USE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MULTI-USE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY GAMMA-IRRADIATED FLOW PATHS, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY GAMMA-IRRADIATED FLOW PATHS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY GAMMA-IRRADIATED FLOW PATHS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRESTERILIZED ASSEMBLIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRESTERILIZED ASSEMBLIES, BY GROUP, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRESTERILIZED ASSEMBLIES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CELL CLARIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CELL CLARIFICATION, BY GROUP, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CELL CLARIFICATION, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY POLISHING & FINAL PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY POLISHING & FINAL PURIFICATION, BY GROUP, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY POLISHING & FINAL PURIFICATION, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, BY GROUP, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 97. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY ENZYME PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 98. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY ENZYME PURIFICATION, BY GROUP, 2018-2030 (USD MILLION)
TABLE 99. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY ENZYME PURIFICATION, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 100. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 101. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2030 (USD MILLION)
TABLE 102. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 103. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PEPTIDE PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 104. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PEPTIDE PURIFICATION, BY GROUP, 2018-2030 (USD MILLION)
TABLE 105. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PEPTIDE PURIFICATION, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 106. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY RECOMBINANT PROTEIN PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 107. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY RECOMBINANT PROTEIN PURIFICATION, BY GROUP, 2018-2030 (USD MILLION)
TABLE 108. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY RECOMBINANT PROTEIN PURIFICATION, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 110. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY VACCINE PRODUCTION, BY GROUP, 2018-2030 (USD MILLION)
TABLE 111. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY VACCINE PRODUCTION, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 112. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY VIRUS PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 113. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY VIRUS PURIFICATION, BY GROUP, 2018-2030 (USD MILLION)
TABLE 114. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY VIRUS PURIFICATION, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 115. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 117. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2030 (USD MILLION)
TABLE 118. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 119. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 120. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2018-2030 (USD MILLION)
TABLE 121. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 122. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY BIOSERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 123. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY BIOSERVICES, BY GROUP, 2018-2030 (USD MILLION)
TABLE 124. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY BIOSERVICES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 125. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 126. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 127. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 128. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 129. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2030 (USD MILLION)
TABLE 130. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 132. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 133. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 134. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 135. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 136. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 137. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MATERIAL FORMAT, 2018-2030 (USD MILLION)
TABLE 138. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE, 2018-2030 (USD MILLION)
TABLE 139. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 141. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. NORTH AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 143. NORTH AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. NORTH AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 145. NORTH AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 146. NORTH AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 147. NORTH AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 148. NORTH AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 149. NORTH AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 150. NORTH AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MATERIAL FORMAT, 2018-2030 (USD MILLION)
TABLE 151. NORTH AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE, 2018-2030 (USD MILLION)
TABLE 152. NORTH AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. NORTH AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 154. NORTH AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. LATIN AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 156. LATIN AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. LATIN AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 158. LATIN AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 159. LATIN AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 160. LATIN AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 161. LATIN AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 162. LATIN AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 163. LATIN AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MATERIAL FORMAT, 2018-2030 (USD MILLION)
TABLE 164. LATIN AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE, 2018-2030 (USD MILLION)
TABLE 165. LATIN AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. LATIN AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 167. LATIN AMERICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MATERIAL FORMAT, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. EUROPE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 182. EUROPE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. EUROPE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 184. EUROPE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 185. EUROPE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 186. EUROPE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 187. EUROPE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 188. EUROPE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 189. EUROPE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MATERIAL FORMAT, 2018-2030 (USD MILLION)
TABLE 190. EUROPE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE, 2018-2030 (USD MILLION)
TABLE 191. EUROPE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. EUROPE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 193. EUROPE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. MIDDLE EAST BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 195. MIDDLE EAST BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. MIDDLE EAST BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 197. MIDDLE EAST BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 198. MIDDLE EAST BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 199. MIDDLE EAST BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 200. MIDDLE EAST BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 201. MIDDLE EAST BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 202. MIDDLE EAST BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MATERIAL FORMAT, 2018-2030 (USD MILLION)
TABLE 203. MIDDLE EAST BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE, 2018-2030 (USD MILLION)
TABLE 204. MIDDLE EAST BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. MIDDLE EAST BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 206. MIDDLE EAST BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 208. AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 210. AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 211. AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 212. AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 213. AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 214. AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 215. AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MATERIAL FORMAT, 2018-2030 (USD MILLION)
TABLE 216. AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE, 2018-2030 (USD MILLION)
TABLE 217. AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 219. AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 221. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 223. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 224. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 225. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 226. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 227. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 228. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MATERIAL FORMAT, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 234. ASEAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 235. ASEAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. ASEAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 237. ASEAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 238. ASEAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 239. ASEAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 240. ASEAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 241. ASEAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 242. ASEAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MATERIAL FORMAT, 2018-2030 (USD MILLION)
TABLE 243. ASEAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE, 2018-2030 (USD MILLION)
TABLE 244. ASEAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. ASEAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 246. ASEAN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. GCC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 248. GCC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. GCC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 250. GCC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 251. GCC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 252. GCC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 253. GCC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 254. GCC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 255. GCC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MATERIAL FORMAT, 2018-2030 (USD MILLION)
TABLE 256. GCC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE, 2018-2030 (USD MILLION)
TABLE 257. GCC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. GCC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 259. GCC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. EUROPEAN U

Companies Mentioned

The key companies profiled in this Biopharmaceutical Bioseparation Systems market report include:
  • Agilent Technologies, Inc.
  • Alfa Laval AB
  • Alfa Wassermann, Inc.
  • Asahi Kasei Corporation
  • Astrea Bioseparations Group by Biotage AB
  • Bio-Rad Laboratories, Inc.
  • Daicel Corporation
  • Danaher Corporation
  • Flottweg SE
  • GE HealthCare Technologies Inc.
  • GEA Group Aktiengesellschaft
  • Gilson Incorporated
  • GL Sciences Inc.
  • Hitachi, Ltd.
  • JASCO Corporation
  • KNAUER Wissenschaftliche Geräte GmbH
  • Merck KGaA
  • PerkinElmer Inc.
  • Repligen Corporation
  • Restek Corporation
  • Sartorius AG
  • Shimadzu Corporation
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Bioscience LLC
  • Waters Corporation
  • YMC CO., LTD.

Table Information

Report AttributeDetails
No. of Pages193
PublishedJanuary 2026
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 15.42 Billion
Forecasted Market Value ( USD ) by 2030 $ 24.38 Billion
Compound Annual Growth Rate9.5%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Biopharmaceutical Bioseparation Systems - Global Strategic Business Report - Product Image

Biopharmaceutical Bioseparation Systems - Global Strategic Business Report

  • Report
  • 360 Pages
  • Global
From
Filtration Market (Focus on Biologics Manufacturing): Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Filtration, Type of Filter, Type of Assembly, Company Size and Key Geographical Regions - Product Image

Filtration Market (Focus on Biologics Manufacturing): Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Filtration, Type of Filter, Type of Assembly, Company Size and Key Geographical Regions

  • Report
  • 165 Pages
  • Global
From
Biopharmaceuticals Manufacturing Consumables Testing Market - Global Forecast 2026-2032 - Product Image

Biopharmaceuticals Manufacturing Consumables Testing Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Biopharma Chromatography Systems - Global Strategic Business Report - Product Image

Biopharma Chromatography Systems - Global Strategic Business Report

  • Report
  • 369 Pages
  • Global
From
Biopharmaceutical Processing Equipment & Consumables Market - Global Forecast 2026-2032 - Product Image

Biopharmaceutical Processing Equipment & Consumables Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From

About the Biopharmaceutical Bioseparation Systems Market

In biotechnology, bioseparation systems are crucial for the purification and analysis of bio-molecules such as proteins, DNA, and antibodies that are used in various biopharmaceutical applications. These systems employ a range of techniques like chromatography, centrifugation, filtration, and electrophoresis to isolate specific biological components from complex mixtures. The demand for these systems is driven by the need for therapeutically and diagnostically relevant biomolecules with high purity and yield. The field is marked by continuous advancement to enhance efficiency, scalability, and cost-effectiveness and to cater to the stringent regulatory standards for biopharmaceutical production. Innovations in the domain often revolve around improving selectivity and reducing processing time. Some notable players in the biopharmaceutical bioseparation systems market include GE Healthcare (now part of Danaher Corporation), Merck KGaA, Thermo Fisher Scientific, and Sartorius Stedim Biotech. These companies provide a range of bioseparation products and services, helping to drive advancements in the preparation of biological products. Each company typically engages in research and development to bring forward innovations in separation technologies that aim to meet the evolving needs of the biopharmaceutical industry. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.